603567 HeiLongJiang ZBD Pharmaceutical
- 12.14
- 0.000.00%
HeiLongJiang ZBD Pharmaceutical News
Zhenbao Island: Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the progress of providing guarantees for wholly-owned subsidiaries
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on the use of some idle funds raised to temporarily supplement working capital
Inspection opinions of Guoxin Securities Co., Ltd. on the use of some idle funds raised by Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. to temporarily supplement working capital
Guoxin Securities Co., Ltd.\'s inspection opinion on the further extension of some fund-raising investment projects of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 14th Meeting of the Fifth Board of Directors of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 12th Meeting of the Fifth Board of Supervisors of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on holding the 2024 semi-annual results briefing
Announcement of the resolution of the eleventh meeting of the fifth board of supervisors of Heilongjiang ZBD Pharmaceutical Co., Ltd.
Heilongjiang ZBD Pharmaceutical Co., Ltd. The Fifth Session of the Board of Directors' Thirteenth Meeting Resolution Announcement
Heilongjiang ZBD Pharmaceutical Co.,Ltd. Special Report on the Deposit and Actual Use of Raised Funds for the First Half of 2024
Announcement of resolutions of the Twelfth Meeting of the Fifth Board of Directors of Heilongjiang ZBD Pharmaceutical Co., Ltd.
Announcement of the Resolution of the Tenth Meeting of the Fifth Supervisory Board of Heilongjiang ZBD Pharmaceutical Co., Ltd.
Announcement of Heilongjiang ZBD Pharmaceutical Co., Ltd. on the Correction of Accounting Errors and Periodic Report Correction.
Announcement of Heilongjiang ZBD Pharmaceutical Co., Ltd. on Obtaining Pharmaceutical Registration Certificate
Legal opinion of Lan Tai Law Firm on differentiated dividend matters of Heilongjiang ZBD Pharmaceutical Co., Ltd. for the year 2023.
Reply to the Information Disclosure Supervision Letter on the Annual Report 2023 of Heilongjiang ZBD Pharmaceutical Co., Ltd. by Zhongzhun Certified Public Accountants (Special General Partnership).
Announcement of the resolution of the ninth meeting of the fifth supervisory board of Heilongjiang ZBD Pharmaceutical Co., Ltd.
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on obtaining a drug registration certificate
Jumbo Island Investor Relations Activity Record List (May 5, 2024)
Announcement of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. on obtaining a drug registration certificate
Analysis
Price Target
No Data
No Data